We have located links that may give you full text access.
Journal Article
Review
[Past, present, and future therapeutically options in age related macular degeneration].
Oftalmologia 2002
Age related macular degeneration is the most common cause of blindness in patients older than 65 years of age and it ranks second after diabetic retinopathy as the leading cause of blindness in the 45 to 64 years age group. Along the time, an important number of therapeutical options was developed, in association with the pathogenic hypothesis: medication, laser treatment, photodynamic therapy, surgical methods, etc. The goal of this paper is to summarize the evolution of the main therapeutical approaches in age related macular degeneration.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app